GJB2 Gene Deafness Autosomal Dominant Type 3A Genetic Test sale cost 4400 AED
COL4A3 Gene Alport syndrome autosomal recessive Genetic Test sale cost 4400 AED COL4A3 Gene Alport syndrome autosomal recessive Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
CCDC50 Gene Deafness Autosomal Dominant Type 44 Genetic Test sale cost 4400 AED CCDC50 Gene Deafness Autosomal Dominant Type 44 Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

GJB2 Gene Deafness Autosomal Dominant Type 3A Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The “GJB2 Gene Deafness Autosomal Dominant Type 3A Genetic Test” is a specialized diagnostic tool designed to identify mutations in the GJB2 gene, which are linked to Autosomal Dominant Deafness Type 3A. This condition is characterized by varying degrees of hearing loss that is passed down through families in an autosomal dominant pattern, meaning only one copy of the altered gene is necessary for the trait to be expressed. The GJB2 gene plays a crucial role in the function of cochlear hair cells and the potassium recycling pathway in the inner ear, which are essential for normal hearing.

Conducted at DNA Labs UAE, a leading facility in genetic testing, this test is priced at 4400 AED. It involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed for specific genetic mutations associated with this form of deafness. The results can provide valuable information for affected individuals and their families, including the confirmation of a genetic diagnosis, understanding the risk of passing the condition to offspring, and guiding decisions about management and treatment options. As with any genetic test, counseling before and after the test is recommended to ensure individuals fully understand the implications of the results.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

GJB2 Gene Deafness autosomal dominant type 3A Genetic Test

Components: GJB2 Gene Deafness autosomal dominant type 3A Genetic Test

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test type: Ear Nose Throat Disorders

Doctor: ENT Doctor

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for SLC52A2 Gene Brown-Vialetto-Van Laere syndrome type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SLC52A2 Gene Brown-Vialetto-Van Laere syndrome type 2 NGS Genetic DNA Test gene SLC52A5

Test Details: The GJB2 gene is responsible for producing a protein called connexin 26, which forms gap junctions between cells in the inner ear. Mutations in the GJB2 gene can lead to a type of deafness known as autosomal dominant type 3A deafness. An NGS (Next-Generation Sequencing) genetic test for GJB2 gene deafness involves analyzing the DNA sequence of the GJB2 gene to identify any mutations or variations that may be present. This test can help diagnose individuals with autosomal dominant type 3A deafness and provide information about the specific genetic cause of their condition. NGS technology allows for the simultaneous analysis of multiple genes, making it a powerful tool for genetic testing. It enables the identification of small genetic changes, such as point mutations or small insertions/deletions, as well as larger structural variations in the GJB2 gene. By identifying the specific genetic mutation causing deafness in an individual, NGS genetic testing can help guide treatment decisions, provide information about the likelihood of passing on the condition to future generations, and facilitate genetic counseling for affected individuals and their families.

Test Name GJB2 Gene Deafness autosomal dominant type 3A Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Ear Nose Throat Disorders
Doctor ENT Doctor
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for SLC52A2 Gene Brown-Vialetto-Van Laere syndrome type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SLC52A2 Gene Brown-Vialetto-Van Laere syndrome type 2 NGS Genetic DNA Test gene SLC52A5
Test Details

The GJB2 gene is responsible for producing a protein called connexin 26, which forms gap junctions between cells in the inner ear. Mutations in the GJB2 gene can lead to a type of deafness known as autosomal dominant type 3A deafness.

An NGS (Next-Generation Sequencing) genetic test for GJB2 gene deafness involves analyzing the DNA sequence of the GJB2 gene to identify any mutations or variations that may be present. This test can help diagnose individuals with autosomal dominant type 3A deafness and provide information about the specific genetic cause of their condition.

NGS technology allows for the simultaneous analysis of multiple genes, making it a powerful tool for genetic testing. It enables the identification of small genetic changes, such as point mutations or small insertions/deletions, as well as larger structural variations in the GJB2 gene.

By identifying the specific genetic mutation causing deafness in an individual, NGS genetic testing can help guide treatment decisions, provide information about the likelihood of passing on the condition to future generations, and facilitate genetic counseling for affected individuals and their families.

SKU: TEST-2687 Category:

Related products